A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches

Antifungal drug resistance is an escalating global health concern that threatens the effective treatment of fungal infections in both clinical and environmental settings. This review synthesizes developments, focusing on molecular and physiological mechanisms of resistance, key contributing factors, and associated therapeutic limitations. Through selected international case studies over the past 5 years (2020-2025), we illustrate the clinical and ecological consequences of resistant fungal pathogens and emphasize the need for coordinated global responses. We also discuss integrated strategies to mitigate this threat, including strengthened surveillance systems, optimized antifungal stewardship, and advancements in diagnostic tools and therapeutic innovation. By consolidating recent insights and identifying critical research gaps, this review aims to inform future investigations and guide policy frameworks to combat antifungal resistance worldwide.

Authors

Institutions

Publication Details

Journal
Indian Journal of Pharmacology
Published
2026-01-01
DOI
https://doi.org/10.4103/ijp.ijp_1129_25
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches

Meera Challapilla, Swathi Gurajala
Indian Journal of Pharmacology
Antifungal resistance and susceptibility
article

A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches

Meera Challapilla, Swathi Gurajala
article en

Abstract

Antifungal drug resistance is an escalating global health concern that threatens the effective treatment of fungal infections in both clinical and environmental settings. This review synthesizes developments, focusing on molecular and physiological mechanisms of resistance, key contributing factors, and associated therapeutic limitations. Through selected international case studies over the past 5 years (2020-2025), we illustrate the clinical and ecological consequences of resistant fungal pathogens and emphasize the need for coordinated global responses. We also discuss integrated strategies to mitigate this threat, including strengthened surveillance systems, optimized antifungal stewardship, and advancements in diagnostic tools and therapeutic innovation. By consolidating recent insights and identifying critical research gaps, this review aims to inform future investigations and guide policy frameworks to combat antifungal resistance worldwide.

Indian Journal of PharmacologyVol. 58(1)
East Suffolk and North Essex NHS Foundation Trust (GB), Ipswich Hospital (GB), Imam Abdulrahman Bin Faisal University (SA)
Industry, innovation and infrastructure
Openalex Percentile: Top 96%
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches — Meera Challapilla, Swathi Gurajala · Indian Journal of Pharmacology (2026) | TGRS Research Map | TGRS